iRhythm announced today that it closed an offering of senior notes worth gross proceeds of $661.25 million. The San Francisco-based cardiac monitor maker said earlier this week that it intends to offer $450 million in convertible senior notes. Approximately 17 hours later, it upsized that offering to a base of $575 million. San Francisco–based iRhythm […]
iRhythm
iRhythm proposes $450M offering
iRhythm announced today that it intends to offer $450 million in convertible senior notes. San Francisco–based iRhythm plans to offer the notes — due 2029 — to qualified institutional buyers. It intends to grant initial purchasers a 13-day option to buy up to an additional $67.5 million in notes. The notes will be senior, unsecured […]
iRhythm teams up with Epic to streamline Zio access
iRhythm announced that it plans to use Epic’s Aura platform to streamline access to its Zio long-term monitoring and telemetry services. With this collaboration, iRhythm can make Zio more readily available to healthcare providers using Epic. That also applies to the more than 250 million patients in the U.S. who have a health record in […]
iRhythm stock dips on mixed Q4 as guidance ‘may disappoint’ investors
iRhythm Technologies shares took a hit today on third-quarter results that came in mixed compared to the consensus forecast. Shares of IRTC fell 5.5% at $108.75 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — remained even. The San Francisco-based heart monitoring technology […]
iRhythm releases strong Q4 prelims, strengthens balance sheet
iRhythm Technologies today released a solid preliminary earnings update that included projections of up to 20% revenue growth in 2024. The wearable cardiac monitors developer saw IRTC shares jump more than 7% in value to $112.91 apiece by the close of trading today. MassDevice‘s MedTech 100 Index, which includes stocks of the world’s largest medical […]
iRhythm wins CE mark for next-gen Zio ECG system, Zeus software
iRhythm Technologies announced today that it received CE mark for its Zio system and its supporting Zeus AI algorithm. San Francisco-based iRhythm designed the next-generation Zio long-term ambulatory cardiac monitor to detect potential cardiac arrhythmias. Zeus, the company’s advanced, deep-learned AI algorithm, supports the capture and analysis of ECG data recorded by Zio. The company […]
iRhythm grows sales by 20% in mixed Q3, offers positive FDA warning letter update
iRhythm Technologies shares ticked up today on third-quarter results that came in mixed compared to the consensus forecast. Shares of IRTC rose 4.4% at $82.66 apiece in mid-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — ticked up 1.7%. The San Francisco-based cardiac monitoring technology […]
iRhythm launches next-gen Zio monitor, enhanced long-term monitoring service
iRhythm Technologies announced today that it launched its next-generation Zio monitor in the U.S. In the launch, San Francisco-based iRhythm also included an enhanced Zio long-term continuous monitoring (LTCM) service. Zio, the company’s smallest, lightest and thinnest cardiac monitor, aims to enhance the cardiac monitoring experience for patients. The company said its new service enhancements […]
The biggest medtech personnel moves so far in 2023
More than halfway through 2023, we’ve seen plenty of movement in the personnel department across medtech. Last July, we broke down the biggest personnel moves in medtech so far in 2022. That was followed up by the full-year report in December. Through more than eight months, the changes atop medtech companies continue to arrive. Some […]
iRhythm sales are up more than 20% amid increasing Zio demand
iRhythm shares rose after hours today on second-quarter results that topped the consensus forecast. Shares of IRTC ticked up 5.6% to $103 apiece after the market closed on Thursday. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down 0.8%. At midday on Friday, shares […]
iRhythm has an FDA warning letter over Zio AT quality systems
iRhythm stock is down today on news of an FDA warning letter involving its Zio AT mobile cardiac telemetry device. In a Form 8-K filed with the SEC yesterday, iRhythm said it received the warning letter on May 25. The warning letter resulted from an FDA inspection at the company’s Cypress, California facility that concluded […]